𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Remoxipride in the treatment of coexistent schizophrenia and parkinson's disease

✍ Scribed by Stephen J. Cooper; Michael M. Doherty

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
267 KB
Volume
4
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis

Schizophrenia and Parkinson's Disease occasionally co-exist in a patient. This poses a therapeutic problem. We report a case in whom remoxipride was useful for this situation.

πŸ“œ SIMILAR VOLUMES

Symptomatic relief from treatment-induce
Symptomatic relief from treatment-induced psychosis in Parkinson's disease: An open-label pilot study with remoxipride
✍ Dr. Tilak Mendis; Erich Mohr; Amanda George; Ilene N. Rusk; Peggy Gray; J. David πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 320 KB πŸ‘ 1 views

## Abstract Current treatment strategies for levodopa‐induced psychosis in Parkinson's disease have had limited success. Remoxipride, a selective D~2~ receptor antagonist, was administered in an open label pilot study to seven parkinsonian patients exhibiting thought disorder. Symptoms improved sig

A double-blind comparative trial of remo
A double-blind comparative trial of remoxipride and haloperidol in the treatment of schizophrenia
✍ R. Deo; S. Soni; S. C. Rastogi; S. Levine; I. Plant; J. Guy Edwards; M. J. Mitch πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 577 KB

A multicentre parallel group study was carried out to compare the efficacy and safety of remoxipride, a new antipsychotic drug, with haloperidol in the treatment of acute schizophrenia. Patients were randomly assigned to the two groups and assessments were made under double-blind conditions. Treatme

Treatment of Parkinson's disease in Spai
Treatment of Parkinson's disease in Spain
✍ Francisco Grandas; Jaime Kulisevsky πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 46 KB

## Abstract To assess the patterns of drug use in Parkinson's disease in Spain, information about the clinical characteristics and current treatment of 1,803 parkinsonian patients was obtained from a nationwide survey, involving 241 physicians with practice based on the different assistance levels

Viral vectors in the treatment of Parkin
Viral vectors in the treatment of Parkinson's disease
✍ David S. Latchman; Robert S. Coffin πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 2 views

s disease is an obvious target for the development of gene therapy procedures which could involve both the delivery of the gene encoding tyrosine hydroxylase to boost dopamine production or the delivery of genes encoding neurotrophic factors such as GDNF to promote the survival of dopaminergic neuro